AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
9.75
-0.20 (-2.01%)
Feb 21, 2025, 4:00 PM EST - Market closed
AVITA Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | 64.25 | 50.14 | 34.42 | 33.03 | 29.23 | Upgrade
|
| Revenue Growth (YoY) | 28.14% | 45.68% | 4.23% | 12.98% | 104.95% | Upgrade
|
| Cost of Revenue | 9.09 | 7.78 | 6.04 | 6.1 | 5.95 | Upgrade
|
| Gross Profit | 55.16 | 42.36 | 28.38 | 26.92 | 23.28 | Upgrade
|
| Selling, General & Admin | 91.39 | 65.63 | 45.24 | 37.92 | 37.06 | Upgrade
|
| Research & Development | 20.36 | 20.82 | 13.86 | 15.67 | 14.82 | Upgrade
|
| Other Operating Expenses | - | -1.43 | -3.22 | -1.59 | -2.06 | Upgrade
|
| Operating Expenses | 111.75 | 85.02 | 55.89 | 52 | 49.82 | Upgrade
|
| Operating Income | -56.59 | -42.66 | -27.51 | -25.08 | -26.54 | Upgrade
|
| Interest Expense | -5.36 | -1.14 | -0.02 | -0.03 | -0.02 | Upgrade
|
| Interest & Investment Income | 2.7 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | 8.5 | 0.89 | 0.05 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -59.29 | -35.32 | -26.63 | -25.06 | -26.55 | Upgrade
|
| Asset Writedown | - | - | - | -0.04 | - | Upgrade
|
| Other Unusual Items | -2.5 | - | - | - | - | Upgrade
|
| Pretax Income | -61.79 | -35.32 | -26.63 | -25.1 | -26.55 | Upgrade
|
| Income Tax Expense | 0.05 | 0.07 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Earnings From Continuing Operations | -61.85 | -35.38 | -26.67 | -25.14 | -26.58 | Upgrade
|
| Net Income | -61.85 | -35.38 | -26.67 | -25.14 | -26.58 | Upgrade
|
| Net Income to Common | -61.85 | -35.38 | -26.67 | -25.14 | -26.58 | Upgrade
|
| Shares Outstanding (Basic) | 26 | 25 | 25 | 24 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 25 | 25 | 24 | 23 | Upgrade
|
| Shares Change (YoY) | 2.18% | 1.32% | 2.64% | 7.42% | 11.75% | Upgrade
|
| EPS (Basic) | -2.39 | -1.40 | -1.07 | -1.03 | -1.17 | Upgrade
|
| EPS (Diluted) | -2.39 | -1.40 | -1.07 | -1.03 | -1.17 | Upgrade
|
| Free Cash Flow | -58.11 | -39.39 | -19.54 | -18.52 | -26.8 | Upgrade
|
| Free Cash Flow Per Share | -2.25 | -1.56 | -0.78 | -0.76 | -1.18 | Upgrade
|
| Gross Margin | 85.85% | 84.48% | 82.45% | 81.52% | 79.65% | Upgrade
|
| Operating Margin | -88.08% | -85.07% | -79.91% | -75.93% | -90.79% | Upgrade
|
| Profit Margin | -96.26% | -70.56% | -77.47% | -76.13% | -90.94% | Upgrade
|
| Free Cash Flow Margin | -90.44% | -78.56% | -56.77% | -56.09% | -91.66% | Upgrade
|
| EBITDA | -55.47 | -42.02 | -26.94 | -24.4 | -25.83 | Upgrade
|
| EBITDA Margin | -86.33% | -83.81% | -78.26% | -73.89% | -88.34% | Upgrade
|
| D&A For EBITDA | 1.13 | 0.63 | 0.57 | 0.67 | 0.72 | Upgrade
|
| EBIT | -56.59 | -42.66 | -27.51 | -25.08 | -26.54 | Upgrade
|
| EBIT Margin | -88.08% | -85.07% | -79.91% | -75.93% | -90.79% | Upgrade
|
| Revenue as Reported | 64.25 | 50.14 | - | - | - | Upgrade
|
| Advertising Expenses | 0.54 | 0.4 | 0.22 | - | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.